Rare diseases
Investigational molecules
Locations
Back to France1 508 clinical trials in Quint-Fonsegrives, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety of Allogeneic Adipose-Derived Mesenchymal Stromal Cells for Patients with Severe Systemic Sclerosis
FranceStudy on Switching from Anti-C5 Antibody Therapy to Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
FranceStudy on the Effects of ZN-c3 for Patients with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
FranceStudy on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia
FranceStudy on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
FranceStudy on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Patients with Resectable Soft-Tissue Sarcoma
FranceStudy on the Effects of Injectable Gentamicin for Patients with Moderate to Severe Congenital Ichthyosis
FranceStudy on Clopidogrel's Effect in Preventing Systemic Sclerosis for Patients with Raynaud's Phenomenon and Specific Immune Conditions
FranceStudy on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation
FranceStudy Comparing Ciprofloxacin, Colistimethate Sodium, and Ceftazidime for Treating Early Airway Infection in Adults with Bronchiectasis
FranceStudy on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors
FranceStudy of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies for both muscle-invasive and non-muscle-invasive cases. Studies also address prostate conditions, from benign hyperplasia to advanced cancer.
Novel approaches combine immunotherapy with targeted treatments to improve patient outcomes.
Comprehensive research into breast cancer treatments, particularly focusing on triple-negative and hormone receptor-positive variants. Studies evaluate new approaches in colon cancer management using circulating tumor DNA analysis.
Investigations combine immunotherapy with traditional treatments for enhanced efficacy.
Research addressing pulmonary conditions and specialized medical needs. Studies include evaluation of treatments for chronic obstructive pulmonary disease and migraine management in emergency settings.
Focus on improving patient quality of life through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
